Insider · CIK 0001705905
M Scot Roberts
Files at ALT (Altimmune, Inc.). First filing -, latest -.
M Scot Roberts files SEC Form 4 as officer at ALT (Altimmune, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; M Scot Roberts has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 32 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jul 31, 2026 | ALT Altimmune, Inc. | AGrant or award Common Stock, par value $0.0001 | +875 | $2.41 | $2,112 | 113,699 | Aug 3, 2026 |
| Feb 26, 2026 | ALT Altimmune, Inc. | AGrant or award Stock Options (option to buy)derivative | +222,670 | $0.00 | $0 | 222,670 | Feb 27, 2026 |
| Feb 26, 2026 | ALT Altimmune, Inc. | AGrant or award Restricted Stock Unitsderivative | +95,430 | $0.00 | $0 | 95,430 | Feb 27, 2026 |
| Jan 30, 2026 | ALT Altimmune, Inc. | MOption exercise Common Stock, par value $0.0001 | +9,275 | $0.00 | $0 | 104,670 | Feb 3, 2026 |
| Jan 30, 2026 | ALT Altimmune, Inc. | FTax withholding Common Stock, par value $0.0001 | -2,859 | $5.60 | $16k | 101,811 | Feb 3, 2026 |
| Jan 31, 2026 | ALT Altimmune, Inc. | AGrant or award Common Stock, par value $0.0001 | +5,567 | $3.07 | $17k | 107,378 | Feb 3, 2026 |
| Feb 2, 2026 | ALT Altimmune, Inc. | MOption exercise Common Stock, par value $0.0001 | +7,775 | $0.00 | $0 | 115,153 | Feb 3, 2026 |
| Feb 2, 2026 | ALT Altimmune, Inc. | FTax withholding Common Stock, par value $0.0001 | -2,329 | $5.55 | $13k | 112,824 | Feb 3, 2026 |
| Jan 30, 2026 | ALT Altimmune, Inc. | MOption exercise Restricted Stock Unitsderivative | -9,275 | $0.00 | $0 | 9,275 | Feb 3, 2026 |
| Feb 2, 2026 | ALT Altimmune, Inc. | MOption exercise Restricted Stock Unitsderivative | -7,775 | $0.00 | $0 | 0 | Feb 3, 2026 |
| Jan 27, 2026 | ALT Altimmune, Inc. | MOption exercise Common Stock, par value $0.0001 | +15,850 | $0.00 | $0 | 100,143 | Jan 29, 2026 |
| Jan 27, 2026 | ALT Altimmune, Inc. | FTax withholding Common Stock, par value $0.0001 | -4,748 | $6.18 | $29k | 95,395 | Jan 29, 2026 |
| Jan 27, 2026 | ALT Altimmune, Inc. | MOption exercise Restricted Stock Unitsderivative | -15,850 | $0.00 | $0 | 47,550 | Jan 29, 2026 |
| Jan 25, 2026 | ALT Altimmune, Inc. | MOption exercise Common Stock, par value $0.0001 | +14,600 | $0.00 | $0 | 88,666 | Jan 27, 2026 |
| Jan 25, 2026 | ALT Altimmune, Inc. | FTax withholding Common Stock, par value $0.0001 | -4,373 | $5.50 | $24k | 84,293 | Jan 27, 2026 |
| Jan 25, 2026 | ALT Altimmune, Inc. | MOption exercise Restricted Stock Unitsderivative | -14,600 | $0.00 | $0 | 29,200 | Jan 27, 2026 |
| Jul 31, 2025 | ALT Altimmune, Inc. | AGrant or award Common Stock, par value $0.0001 | +846 | $3.14 | $2,656 | 74,066 | Aug 4, 2025 |
| Jan 30, 2025 | ALT Altimmune, Inc. | MOption exercise Common Stock, par value $0.0001 | +9,275 | $0.00 | $0 | 62,921 | Feb 3, 2025 |
| Jan 30, 2025 | ALT Altimmune, Inc. | FTax withholding Common Stock, par value $0.0001 | -2,709 | $7.00 | $19k | 60,212 | Feb 3, 2025 |
| Jan 31, 2025 | ALT Altimmune, Inc. | AGrant or award Common Stock, par value $0.0001 | +3,184 | $5.18 | $16k | 63,396 | Feb 3, 2025 |
| Feb 1, 2025 | ALT Altimmune, Inc. | MOption exercise Common Stock, par value $0.0001 | +6,166 | $0.00 | $0 | 69,562 | Feb 3, 2025 |
| Feb 1, 2025 | ALT Altimmune, Inc. | FTax withholding Common Stock, par value $0.0001 | -1,801 | $6.64 | $12k | 67,761 | Feb 3, 2025 |
| Feb 2, 2025 | ALT Altimmune, Inc. | MOption exercise Common Stock, par value $0.0001 | +7,775 | $0.00 | $0 | 75,536 | Feb 3, 2025 |
| Feb 2, 2025 | ALT Altimmune, Inc. | FTax withholding Common Stock, par value $0.0001 | -2,316 | $6.64 | $15k | 73,220 | Feb 3, 2025 |
| Jan 30, 2025 | ALT Altimmune, Inc. | MOption exercise Restricted Stock Unitsderivative | +9,275 | $0.00 | $0 | 18,550 | Feb 3, 2025 |
| Feb 1, 2025 | ALT Altimmune, Inc. | MOption exercise Restricted Stock Unitsderivative | +6,166 | $0.00 | $0 | 0 | Feb 3, 2025 |
| Feb 2, 2025 | ALT Altimmune, Inc. | MOption exercise Restricted Stock Unitsderivative | +7,775 | $0.00 | $0 | 7,775 | Feb 3, 2025 |
| Jan 25, 2025 | ALT Altimmune, Inc. | MOption exercise Common Stock, par value $0.0001 | +14,600 | $0.00 | $0 | 57,910 | Jan 28, 2025 |
| Jan 25, 2025 | ALT Altimmune, Inc. | FTax withholding Common Stock, par value $0.0001 | -4,264 | $6.98 | $30k | 53,646 | Jan 28, 2025 |
| Jan 25, 2025 | ALT Altimmune, Inc. | MOption exercise Restricted Stock Unitsderivative | +14,600 | $0.00 | $0 | 43,800 | Jan 28, 2025 |
| Jan 27, 2025 | ALT Altimmune, Inc. | AGrant or award Stock Options (option to buy)derivative | +183,600 | $0.00 | $0 | 183,600 | Jan 28, 2025 |
| Jan 27, 2025 | ALT Altimmune, Inc. | AGrant or award Restricted Stock Unitsderivative | +63,400 | $0.00 | $0 | 63,400 | Jan 28, 2025 |
Questions about M Scot Roberts
Answered from the filings on this page, as of the latest one.
Is M Scot Roberts buying or selling?
M Scot Roberts has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did M Scot Roberts's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and M Scot Roberts has 0.
Where does M Scot Roberts file Form 4?
M Scot Roberts has filed Form 4 at ALT (Altimmune, Inc.) as Chief Scientific Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.